Application of a particle filtration method in the search for new bioactive natural products from fungi by Yusof, Mohd Termizi Bin
 March 2008 
 
 
 
Application of a particle filtration method in the search for new 
bioactive natural products from fungi. 
  
         
 
 
A thesis submitted in partial fulfilment of the requirements  
for the Degree of  
 
Master of Science in Microbiology  
 
in the University of Canterbury  
 
by  
 
Mohd. Termizi bin Yusof 
 
 
 
 
 
 
 ABSTRACT 
 
Fungi have been an important source for producing a wide range of secondary 
metabolites of widely differing chemical structures, as well as biological activities. Many 
of their metabolites now play a major role in pharmaceutical and agricultural industries.  
 
A number of fungi were isolated from soil and leaf litter collected from Arthur’s Pass, 
West Coast and Kaituna Valley using a particle filtration technique. Fungi were selected 
based on their unusual morphology or observed cytotoxicity and antimicrobial activity 
for large scale culture and extraction. 
 
A pale yellow compound was isolated from cytotoxic extracts from the culture of 
Aspergillus versicolor. This compound was identified as sterigmatocystin and the identity 
confirmed by UV profile and mass spectrometry. 
 
Five compounds were isolated from extracts prepared from two different species of 
Penicillium of which three were active against P388 cells (mycophenolic acid, 
cycloaspeptide A and mevastatin), one was active against dermatophytes (griseofulvin) 
and one was not active (3,4,6,8-tetrahydroxy-3-methyl-3,4-dihydroisocoumarin). 
 
Two compounds were isolated from extracts prepared from two different species of 
Phoma. A dark red compound was found to be novel and showed activity against P388 
cells and Bacillus subtilis. A second compound also showing cytotoxicity was identified 
as the known compound phomenone. 
 
A further new compound was isolated from extracts of an identified dematiaceous 
fungus. This alkyl glucoside, however, was not bioactive. 
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Chapter 1 
 
 
Introduction 
 
 
1.1  Fungi 
Fungi are a kingdom of eukaryotic organisms. They are distantly related to plants and 
more closely related to animals but rather different from either of those groups. About 
70,000 species of fungi have been described, however, some estimates of total numbers 
suggest that 1.5 million species may exist (Hawksworth et al., 1995). They are mainly 
multicellular organisms which composed of long and thread like cells connected end to 
end called hyphae which in mass are constitute the mycelium. Some fungal species also 
grow as single cells. Their cell wall is rigid and largely composed of chitin. Most fungal 
species are non-motile and reproduce by means of spores. Both sexual and asexual spores 
may be produced depending on the fungal species and the environment (Kendrick, 1992). 
 
Fungi play an important role in maintaining the ecosystem. By breaking down dead 
organic material, they continue the cycle of nutrients through ecosystems. In addition, 
most vascular plants could not grow without the symbiotic fungi or mycorrhizae, which 
inhabit their roots and supply essential nutrients. 
 
Fungi are also of great economic importance as they have both positive and negative 
effects on us. Some are used in the beer and champagne industry, provide numerous 
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drugs such as penicillin and other antibiotics, foods like mushrooms, truffles and morels. 
Some are also studied as model organisms that can be used to gain knowledge of basic 
processes such as genetics, physiology, biochemistry, and molecular biology which are 
applicable to many organisms (Taylor et al., 1993). At the same time, fungi also 
contribute to the loss of millions of dollars in damage through food spoilage, destruction 
or degradation of materials used by humans, and diseases of plants as well as humans and 
animals (Mueller et al., 2004). 
 
 
1.2 Bioactive metabolites from fungi 
Nature has proven and continues to be a promising source for the discovery of bioactive 
compounds, important for the development of new pharmaceuticals and agrochemicals. 
Microorganisms, especially fungi are significant in this respect (Schulz et al., 2002). 
Fungi are of major interest because only a small percentage of them have been 
investigated for their role in producing novel bioactive compounds and hence offer huge 
potential. To date, soil fungi have yielded most of the compounds presently in 
commercial use. These bioactive compounds are mostly derived from fungal secondary 
metabolism.  
 
Secondary metabolic pathways are not necessarily required for the organisms to survive. 
The induction of secondary metabolism is usually in response to external stimuli such as 
nutritional changes, infection and interspecies competition. The products of secondary 
metabolism are called secondary metabolites and many fungal secondary metabolites 
have found a place in medicine or agriculture.  
 
Important examples of fungal secondary metabolites used in the pharmaceutical industry 
include the penicillins and cephalosporins. Penicillin was first isolated from Penicillium 
notatum in 1929 by Alexander Fleming and became the wonder drug of the age (Keller et 
al., 2005). Cephalosporin was first isolated from Cephalosporium acremonium in 1948 
by Giuseppe Brotzu (Weil et al., 1995). Both penicillins and cephalosporins are β-lactam 
antibiotics, which are usually used for prevention or treatment of bacterial infection. They 
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act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. Figure 
1.1 shows the core structure of penicillin and cephalosporin which has been manipulated 
to give rise to different types of penicillin and cephalosporin with different properties. 
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Figure 1.1 Core structure of penicillin (left) and cephalosporin (right). 
 
Another important group of fungal secondary metabolite of pharmacological importance 
are the statins. An example of a statin that available commercially is lovastatin, which is 
used for lowering cholesterol in those in those with hypercholesterolemia and thus 
preventing heart disease. It was first isolated from Aspergillus terreus. Lovastatin lowers 
cholesterol level by acting as an inhibitor of HMG-CoA reductase, an enzyme that 
catalyzes the conversion of HMG-CoA to mevalonate. Mevalonate is a required building 
block in cholesterol synthesis (Tobert, 2003). 
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Figure 1.2 Structure of lovastatin. 
Cyclosporin is another important one of the fungal secondary metabolites used in 
medicine and was first isolated from Tolypocladium inflatum. It is an immunosuppressant 
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drug used in post-allogeneic organ transplant to lower the risk of organ rejection. It does 
this by binding to cyclophilin of immunocompetent lymphocytes which is responsible for 
activating the transcription of interleukin-2. It also inhibits lymphokine production and 
interleukin release, thus reduces the function of effector T-cells. Figure 1.3 shows the 
structure of cyclosporin A which is available commercially. 
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Figure 1.3 Structure of cyclosporin A. 
 
Gibberellin is an example of a fungal secondary metabolite used in agriculture. It is a 
hormone that plays important roles in plant development such as stem elongation, 
germination, dormancy, flowering, sex expression, enzyme induction as well as leaf and 
fruit senescence. It was first isolated from Gibberella fujikuroi (Tudzynski and Holter, 
1998). Figure 1.4 shows several types of gibberellins that have been isolated from fungi. 
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Figure 1.4 Structure of gibberellin GA3 (left) and gibberellin A17 (right) 
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1.2.1 Classification of secondary metabolites 
Secondary metabolites can be divided into several chemical classes. Most fungal 
secondary metabolites fall into four main chemical classes; peptides, alkaloids, terpenes 
and polyketides. 
 
Peptide metabolites can be either ribosomal peptides or nonribosomal peptides. 
Ribosomal peptides are synthesized by translation on mRNA. These kind of peptides 
usually undergo a post-translational modification after it is being translated. Fungal 
nonribosomal peptides, which are synthesized by specific enzymes rather than the 
ribosomes and are termed nonribosomal peptide synthetases. Examples of fungal peptides 
include penicillin, which has anti-bacterial properties and destruxin A, which has 
insecticidal as well as anti-viral properties. 
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Figure 1.5 Structure of destruxin A 
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Alkaloids are derivatives of amino acids. Many alkaloids possess pharmacological effects 
on humans and animals. They can be further divided into 9 groups (pyridine, pyrrolydine, 
tropane, quinoline, isoquinoline, phenetylamine, indole, purine, terpenoid and vinca 
alkaloids) based on the metabolic pathway used to construct the molecule. Examples of 
fungal alkaloids are ergopeptides, used to treat migraine as well as Parkinson’s disease 
and fumitremorgen C, a mycotoxin.  
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Figure 1.6 Structure of ergopeptides (left) and fumitremorgen C (right). 
 
Terpenes are a large and varied class of hydrocarbons. They are derived from 
polymerization of isoprene subunits. The basic molecular formula for terpenes is (C5H8)n, 
where n is the number of linked isoprene units. The terpene metabolites can be further 
divided into hemiterpenes, monoterpenes, sesquiterpenes, diterpenes, sesterterpenes, 
triterpenes and tetraterpenes, depending on their size. Examples of fungal terpenes are 
vomitoxin and gibberellin GA3. Vomitoxin possesses mycotoxin properties while 
gibberellin is a plant growth regulator. 
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Figure 1.7 Structure of vomitoxin. 
 
Polyketides are the most abundant fungal secondary metabolites and have an extremely 
broad range of biological activities and pharmacological properties. Polyketides are 
derived from the condensation of acetyl-SCoA with malonyl-ScoA units. For fungal 
polyketides, the enzymes responsible for their synthesis are type I polyketide synthases 
(Keller et al., 2005). Examples of fungal polyketides include the mycotoxic aflatoxins 
and lovastatin, a cholesterol lowering agent. 
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Figure 1.8 Structures of several types of aflatoxins, aflatoxin B1 (left) and aflatoxin 
B3 (right). 
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1.3 Fungal isolation 
Fungi have proven and continue to be promising producers of novel bioactive 
compounds. They occupy many ecological niches and the majority of fungi are still 
awaiting discovery. Soil and less so plant litter has been the habitat of choice in the past 
for fungal isolation, however, soil and plant litter offer further potential since it has been 
shown that an abundance and diversity of microfungi exist in soil and litter which could 
be accessed using specialised techniques (Bills and Polishook, 1994).  
 
Currently, other habitats such as plant tissues (endophytes) and the marine world are 
being explored in the search for rare and new fungi which hopefully will lead to the 
discovery of novel bioactive compounds. Habitats with extreme environments such as 
Antarctica (Arenz et al., 2006) and hot springs are also promising sources for isolating 
rare fungi.   
 
The type of fungal species that can be isolated from the environment is dependent on the 
isolation methods used. Conventional isolation methods which examine sporulating 
structures formed on plant material in moist chambers and dilution plating of soil have 
been routinely used in the past. These techniques tend to select for vigorous, fast growing 
fungi which are dominant and usually will overgrow the less vigorous fungi on artificial 
media. Many of these dominant fungi have been isolated and studied thoroughly and 
form the basis of present utilised fungal secondary metabolites. To attempt to isolate less 
readily culturable organisms, with the hope of finding new strains and consequent 
potential for novel bioactivity, more selective methods are required. Examples of 
selective methods are baiting, chemical pasteurization methods, environmental selection 
techniques and particle filtration.  
 
Baiting is a technique in which the artificial medium is enriched nutritionally to favour 
organisms of interest. This way, the organism of interest will have better chance to grow. 
The baiting isolation technique has been widely used for isolation of cellulolytic fungi, 
keratinolytic fungi and entomopathogenic fungi (Klingen et al., 2002). One example of a 
chemical pasteurization technique is ethanol and phenol pasteurization which is a 
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specialized technique usually used to selectively isolate ascomycetes from soil. In 
environmental selection techniques, the manipulation of several parameters such as 
temperature, pH, osmolarity can gives rise to different groups of fungi. 
 
In this study, a particle filtration technique was used to maximize the number of fungal 
isolates obtained from soil and litter samples. This technique is one of a number of 
indirect methods for isolating fungi and a hybrid between the methods used in the 
isolation of soil fungi and leaf endophytic fungi. The Particle filtration technique enables 
the elimination of common and fast growing fungi which then enables the less culturable 
fungi to grow. With careful selection and the help of potent and non-lethal colony 
restriction agents as well as temperature, a high species level should be achieved with 
anticipated ‘rarer’ strains being isolated. 
  
 
1.4 The aim of this study 
It is hypothesised that the development and utilisation of selective isolation techniques 
for soil and litter fungi will result in the identification of new strains which have the 
potential to produce new bioactive metabolites. A contribution to New Zealand 
biodiversity will be made and hopefully new metabolite lead structures characterised with 
potential for pharmaceutical or agrochemical products. 
 
Aims: 
1. Isolation of litter fungi using a particle filtration technique. 
2. Fungal identification by conventional and molecular techniques. 
3. Screening for bioactivity in extracts of isolated fungi. 
4. Characterisation of active metabolites. 
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Chapter 2 
 
 
Methodology 
 
 
2.1 Sampling 
Soil samples from the South Island of New Zealand were collected from Klondyke 
Corner, Arthur’s Pass. Leaf litter samples were collected from three sites. The first site 
was at Carew Falls (West Coast), the second at Mount French (West Coast) and the third 
in Kaituna Valley (Banks Peninsula). There were two types of leaf litter samples 
collected at the first two sites (Carew Falls and Mount French), Rimu leaf litter and 
mixed leaf litter of native trees. Only a mixed litter sample was collected at Kaituna 
Valley. All the samples were kept in sealed sterile bags and stored in a cold room prior to 
further processing. 
 
 
2.2 Media  
The medium used for initial fungal isolation from samples was potato dextrose agar 
(PDA) (BD) supplemented with 50 mg/L of chlortetracycline HCL (Sigma) and 250 
mg/L of streptomycin sulphate (Sigma). For futher culturing and extraction, no antibiotic 
was included in the medium. 
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2.2.1 Preparation of Potato dextrose agar (PDA) 
Potato dextrose agar was prepared according to the manufacturers recommendations. For 
culturing and extraction work, after autoclaving, the agar was poured into Petri dishes 
immediately, approximately 20 mL to 25 mL each plate. For isolation work, 6 mL of the 
antibiotic stock solution was added to cooling agar and poured into Petri dishes. All 
plates were stored at 4°C. 
 
2.2.2 Preparation of stock antibiotic solution 
100 mL of stock antibiotic solution was prepared. 500 mg of chlortetracycline HCL and 
2500 mg of streptomycin sulphate were added to 50 mL distilled water. The mixture was 
stirred until fully dissolved and the solution poured into a 100 mL volumetric flask, made 
up to 100 mL with distilled water and mixed well. The antibiotic solution was then 
filtered using a 0.2 μm sterile filter into a sterile bottle and stored at -20°C. 
 
 
2.3 Isolation of soil fungi and endophytes 
 
2.3.1 Preparation of soil and leaf litter samples 
Soil samples were taken from the cold room and air dried in a laminar flow unit, before 
proceeding with the isolation process. Leaf litter samples were surface sterilized before 
isolation. 
 
The leaf litter samples were shredded by either hand or scissors, placed in a strainer and 
washed thoroughly under running tap water for at least 10 minutes. They were then 
drained and transferred into a beaker and further work conducted in a laminar flow. 
 
First, the leaf pieces were immersed in 70% ethanol for 1 minute with a little agitation. 
Second, the leaf pieces were immersed in 50% NaOCl solution for 3 minutes with a little 
agitation and strained before immersing again in 70% ethanol for 30 seconds. Finally, the 
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leaf pieces were rinsed 3 times with sterile distilled water before spreading out onto 
sterile Whatman No. 1 filter papers and air dried under a stream of sterile air. 
 
2.3.2 Particle filtration technique 
A particle filtration technique was used to isolate fungi from the soil and leaf litter 
samples adapted from that of Bills and Polishook, (1994). The filtration system shown in 
Figure 2.1 consisted of a micro-sieve of three interchangeable screen holding cylinders 
of molded PVC with inner diameter of 55 mm. The cylinders can be unscrewed easily for 
changing filters, cleaning and disinfecting. 
 
All the apparatus involved in this technique was either sterilized by autoclaving or 
swabbing with 70% ethanol. The particle filtration device was disassembled and soaked 
in 70% ethanol. After that, the particle filtration was reassembled with 3 different size of 
polypropylene filters (Spectrum) incorporated into it. The 500 μm filter was put on top, 
200 μm was put in the middle and the 105 μm filter was put at the bottom. Refer to 
Figure 2.1 for detail of the device. The assembled column was held under a tap by a 
burette clamp mounted on a ring stand. 
 
Both soil and leaf litter samples were fragmented separately using a Waring blender. 3 g 
of either soil or leaf litter sample were then put on the top of the filter column and the 
fragments were wet gradually by running a fine spray of tap water for 10 minutes over 
the sample. 
 
After 10 minutes, the particle filtration column was disassembled and the 105 μm filter 
was taken out and placed into a sterile 50 mL centrifuge tube. 50 mL of sterile distilled 
water was added. Then, the tube was agitated to wash off the particles from the filter. The 
105 μm filter was then taken out from the centrifuge tube and the particles allowed to 
settle. The particles were then washed twice with sterile distilled water before a final 1 
mL of sterile distilled water was added to the centrifuge tube. 
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The 1 mL particle solution was then diluted 4 times with sterile distilled water before 100 
μL was spread onto 4 PDA plates supplemented with antibiotics. All plates were sealed 
with either parafilm or plastic wrap and kept at 25°C in the dark.    
 
2.3.3 Maintenance of fungal isolates 
Isolation plates were observed daily for 30 days. Any visible colonies growing were 
subcultured immediately onto fresh PDA without antibiotics. All cultures were then 
incubated at 25°C. 
 
2.3.4 Storage of fungal isolates 
For working and short term storage, the fungal isolates were maintained on a PDA plate 
and kept at 25°C. For mid term storage, 7 to 8 mycelial discs of the fungal isolates were 
transferred into a cryovial tube filled will 1 mL of sterile distilled water and kept at 4°C. 
 
For long term storage, 7 to 8 mycelial discs of each isolates were transferred into a 
cryovial tube filled with 1 mL of sterile 10% glycerol solution, kept at 4°C for 2 hours 
and then transferred into a freezer at -20°C overnight before placing in a -80°C freezer. 
 
 
2.4  Identification of fungal isolates  
Fungal isolates were identified morphologically using microscopy and genetically by 
sequencing the ITS region of the isolated fungal DNA. 
 
2.4.1  Morphological identification of fungal isolates 
Microscopic fungal structures that are crucial for fungal identification such as the fruiting 
structures and spores were examined using a compound microscope with magnification 
up to 400X. Stains used for slide preparation were either lactophenol cotton blue or 
Meltzer’s solution or 0.03% lactofuschin. A small piece of fungal mycelium was scraped 
from the agar plate using either a needle or scalpel and placed into a drop of 70% ethanol 
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Sample 
500 m filter μ
200 m filter μ
105 m filter μ
 
 
 
 
 
Figure 2.1 Particle filtration column. (Top) Filtration column showing positioning of 
the 3 filters. (Bottom) Interior of the filtration column showing filter supports within 
column. 
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on a microscope slide. After the ethanol evaporated, a drop of appropriate stain was 
applied to the fungal mycelium. After that, a cover slip was gently placed on top of the 
stain and pressed gently. The slide was now ready for examination under the compound 
microscope. 
 
2.4.2  Sequencing of ITS region of fungal DNA 
For DNA extraction, the fungal isolates were cultured onto plates of PDA overlaid with 
colourless cellophane and incubated for several days depending on the isolate at 25°C. 
Approximately 100mg of mycelium was harvested and frozen at -20°C. Mycelium was 
ground in liquid nitrogen, mixed with 500 μL of extraction buffer and incubated at 65°C 
for 40 minutes. The solution was then mixed with an equal volume of phenol-chloroform-
isoamyl alcohol (25:24:1) and centrifuged at 10 000 rpm for 10 minutes. The supernatant 
was extracted again with one volume of chloroform-isoamyl alcohol (24:1). DNA was 
precipitated by addition of an equal volume of ice-cold isopropanol and centrifugation at 
10 000 rpm for 10 minutes. Pellets were washed twice in 70% ethanol and air dried at 
37°C. DNA was resuspended in 50 μL of MBG water and stored at -20°C prior to further 
analysis.  
 
The entire ITS1-5.8s-ITS2 region of ribosomal DNA was amplified and sequenced using 
the primers ITS5 and ITS4 (White et al. 1990). PCR reactions with a total volume of 50 
μL contained 0.4 μM of each primer (Invitrogen), 200 μM dNTPs (Innovative Sciences) 
5 μL reaction buffer buffer , 2.5 mM MgSO4,  1 μL BSA , 2 μL of template DNA and 0.7 
U Expand HiFidelity Taq (Roche). The temperature profile for PCR was 30 cycles of 30 
seconds at 94°C, 30 seconds at 56°C, 45 seconds at 72°C using an Eppendorf 
mastercycler. PCR products were visualised by gel electrophoresis and cleaned using 
PerfectPrep Gel cleanup kit (Eppendorf). PCR products were quantified using a 
spectrophotometer and sequenced in both forward and reverse directions (DNA 
Sequencing Facility, University of Canterbury, New Zealand). Forward and reverse 
sequences were assembled into consensus using ChromasPro Version 1.34 
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(Technelysium Pty Ltd). The sequence was then compared with the genebank database to 
determine the identity of the fungal isolates.  
 
       
2.5 Extraction of isolates for bioassay and 
chemical studies 
Fungal cultures prepared for extraction were grown on PDA plates at 25°C for 30 days. 
After 30 days, the agar was cut into pieces, transferred into a test tube and 25 mL of ethyl 
acetate added to the tube. The work was conducted in a fume cupboard. The agar was 
then homogenized using a homogenizer (Janke & Kunkle), test tube covered with 
aluminium foil and left in the fume cupboard overnight. The following day, the ethyl 
acetate layer was transferred into a 100 mL beaker using a 1 mL micropipette. Then, 20 
mL of ethyl acetate was added to the test tube and left in the fume cupboard for at least 8 
hours. The ethyl acetate layer was then transferred into a beaker. Another 20 mL of ethyl 
acetate was then added into the test tube and left in the fume cupboard for at least 6 hours 
and then the ethyl acetate layer transferred into a beaker. 
 
The ethyl acetate extract was then filtered using a 0.45 μm PTFE membrane filter into a 
pre-weighed vial and dried using either nitrogen or a centrifugal evaporator and stored at 
4°C. The dry weight of the concentrated extract was determined and dissolved in HPLC 
grade methanol to a concentration of 1 mg/mL.  
 
 
2.6 Bioassays 
Cytotoxicity and antimicrobial assays were conducted. 
   
2.6.1 P388 quick screen assay 
Murine cell line P388 (ATCC CCL 46, P388D1) used in this assay was grown in MEM 
(minimal essential media) supplemented with 10% fetal calf serum, 266 μg/mL of  
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  30 day old fungal culture on solid media. 
Homogenize the mycelium in a test tube. 
Add 25 mL of ethyl acetate and leave overnight. 
Filter the ethyl acetate extract using a 0.45 μm filter 
into a pre-weighed vial and let it dry. 
Transfer the ethyl acetate layer to a beaker. 
Add 20 mL of ethyl acetate and leave for at least 
8 hours. 
Determine the dry weight of the extract and dissolve it 
in methanol to a concentration of 1 mg/mL. 
Add 20 mL of ethyl acetate and leave for at least 
6 hours. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2 Summary of extract preparation process. 
 
 17
Chapter 2: Methodology 
penicillin, 132 μg/mL of streptomycin, 2 mM L-glutamine, 2.2 g/L of NaHCO3 and 7.4 
mM HEPES. The negative control used was a cell free medium while the positive control 
used was analyte free cell.  
 
5 μL of crude extracts (1 mg/mL) were pipetted into a 96 well microtitre plate which was 
then left to dry in a fume cupboard. After that, 150μL of the P388 cells were added to 
each well and incubated at 36°C for 3 days. 20 μL of MTT tetrazolium, a yellow dye, 
were added into each well and incubated for 4 hours at 36°C. Non-viable cells cannot 
metabolise this dye, whereas viable cells reduce this dye to MTT formazan resulting in an 
intense purple colour. Then, 170 μL of 0.08 HCl in isopropanol was added to each well. 
Finally, the cell viability can be calculated by measuring the absorption of each well at 
540 nm, subtracting the absorption at 690 nm and using the negative and positive control 
as 0% and 100% growth reference respectively. Extracts that inhibit at least 50% of the 
cell growth were then subjected for IC50 assay. 
 
2.6.2  P388 IC50 assay 
P388 IC50 assay consists of a two dilution series of the sample of interest followed by 
incubation with P388 cells in microtitre plates as described in 2.6.1.  
 
The concentration of sample required to reduce cell growth by 50% when compared to 
controls, is expressed as an IC50 (Inhibitory Concentration) in ng/mL. The concentration 
is determined by using the absorbance values obtained at 540 nm after the yellow dye 
MTT tetrazolium is reduced to purple MTT formazan. Result that was expressed as < 
IC50 or > IC50 value indicates that the result is off scale and the sample needs to be 
retested at lower or higher concentrations respectively. 
 
2.6.3  Antimicrobial quick screen assay 
The Gram-positive bacterium, Bacillus subtilis, Gram-negative bacterium, Pseudomonas 
aeruginosa and the fungus, Candida albicans, were used for the purpose of this assay. 
The positive and negative controls used were the same as described in 2.6.1. For activity 
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against C. albicans, 20 μL of crude extracts (1 mg/mL) were pipetted into a 96 well 
microtitre plate, while for the activity against bacteria, 10 μL of crude extracts (1 mg/mL) 
were pipetted into a 96 well microtitre plate. 200 μL of appropriate microorganisms were 
then added into each well and left for 24 hours at 30°C. After that, 30 μL of resazurin, a 
blue dye, was added into each well and left for another 24 hours (plates containing 
Candida albicans and Pseudomonas aeruginosa) or half to an hour (plates containing 
Bacillus subtilis) at 30°C. Resazurin is a growth indicator and the presence of bacteria or 
fungi is indicated by oxygen emission which reacts with resazurin, generating a pink 
color. The cell viability can then be calculated the same way as in 2.6.1, but measuring 
the absorption at 600 nm and subtracting the absorption at 690 nm. 
 
 
2.7 High Pressure Liquid Chromatography 
(HPLC) 
Analytical HPLC was carried out using Dionex liquid chromatograph equipped with a 
UVD 340U diode array detector and connected to an Alltech ELSD 800. The column 
used was Phenomenex Luna C18 (10 × 250 mm, 5 μm). The standard gradient program 
was: 2 minutes of 10% ACN/H2O; a linear gradient to 75% ACN/H2O for 12 minutes; 
isocratic at 75% for another 10 minutes; a linear gradient for 2 minutes to 100% 
ACN/H2O followed by isocratic at 100% ACN for 4 minutes then returned to 10% 
ACN/H2O in 2 minutes and re-equilibrated for 8 minutes with a flow rate of 1 mL/min at 
40°C. 
 
2.7.1 HPLC screening 
30 μg of samples were injected into the HPLC. The samples were analysed based on 
reverse phase chromatography with the standard gradient as in 2.7. For the purpose of 
this screening the mili-Q H2O used was acidified with 0.05% trifluoroacetic acid (TFA). 
The presence of metabolites were then indicated by both UV and ELSD traces, which 
were compared with database spectra to identify metabolites. 
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2.7.2 P388 HPLC assay 
250 μg of selected crude extracts were injected into the HPLC. Samples were analysed by 
reverse phase chromatography using the standard gradient given in 2.7. The eluent was 
collected in a 96 well polystyrene mictotitre plate. From this master plate, based on the 
IC50 results, 5 μL, 50 μL or 100 μL were transferred into a daughter plate. The daughter 
plate was then dried using a centrifugal evaporator and assayed against P388 cells as 
described in 2.6.1. 
 
2.7.3 Antimicrobial HPLC assay 
250 μg of selected crude extracts were injected into the HPLC. The samples were 
analysed based on reverse phase chromatography using the standard gradient as given in 
2.7. The eluent was collected in a 96 wells polystyrene mictotitre plate and dried using 
the centrifugal evaporator before being assayed against appropriate microorganisms as 
described in 2.6.3.  
 
 
2.8 Preparation of samples for CapNMR 
750 μg of crude extracts were injected into the HPLC. Samples were analysed based on 
reverse phase chromatography with the standard gradient as described in 2.7. The eluent 
was collected in a 96 well polypropylene microtitre plate and dried using the centrifugal 
evaporator. The amount of samples were then determined based on the ELSD trace. The 
sample was only subjected to CapNMR if the ELSD trace was at least 500% of the ELSD 
base peak. 
 
 
2.9 Capillary-probe Nuclear Magnetic Resonance 
(CapNMR)   
 1H, COSY, HSQC and HMBC experiments were all conducted on a Varian INOVA 500 
spectrometer at 23°C and 500 MHz. The 500 MHz Protasis Capillary NMR probe was 
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attached to the NMR. Coupling constants (J) were expressed in Hz while chemical shifts 
were expressed in parts per million (ppm) on the δ scale. 
 
From 2.8, the well of interest containing pure or partially pure compound was selected 
and dissolved in 6 μL of deuterated methanol, and injected into an inlet capillary using a 
syringe. A further 11 μL of deuterated methanol was injected to push the sample in the 
probe. After the reading was recorded, the sample was collected back into silated HPLC 
vials or inserts and kept at 4°C.  
 
 
Figure 2.3 CapNMR 
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2.10 Electrospray ionization mass spectrometry 
(ESIMS) 
Electrospray ionization mass spectra were recorded in positive and negative modes on a 
Micromass (Machester, UK) quadrupole time of flight (QTOF-2) mass spectrometer. The 
measurements were performed by Dr. Marie Squire and Mr. Robert Stainthorpe 
(Department of Chemistry, University of Canterbury). 
 
 
2.11 Glassware deactivation (silanization) for 
CapNMR 
All items were immersed into 5% dimethyldichlorosilane (DMDCS) solution for 5 to 30 
minutes. After that, the 5% DMDCS solution was poured off and the items were rinsed 
with methylene chloride immediately. Then, the items were immersed in methanol for 15 
to 30 minutes. Finally, the methanol was drained off and items kept in 100°C oven to dry 
completely.     
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Preliminary screening 
 
 
3.1 Fungal isolates from soil and leaf litter 
A total of 232 fungal isolates were obtained from the soil (60 isolates) and leaf litter 
samples (172 isolates) (Table 3.1). A preliminary identification of the fungal isolates was 
made based on morphological and cultural characteristics. At this stage, many could only 
be identified to the genus level, however, most of the fungal isolates obtained could not 
be identified morphologically because of the absence of spores. For those non-sporing 
active isolates, DNA sequencing was used in an attempt to clarify their identity. 
 
The total number of fungal cultures isolated here, is much less than that reported by Bills 
and Polishook (1994) who isolated a total of 1709 cultures from leaf litter collected from 
four different sites. Paulus et al. (2003) isolated 1365 cultures from leaf litter collected 
from eight different samples. In their studies however, greater replication and several 
media types for primary isolation were used.   
 
Most of the fungal cultures isolated in this study were sterile and a number of slow 
growing fungi have also been isolated. This is consistent with the results of Bills and 
Polishook (1994) and Paulus et al. (2003) who noted isolation of sterile fungi with this 
technique. 
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Table 3.1 Fungal isolates obtained from soil and leaf litter samples. 
Sampling sites Samples Number of isolates
Klondyke Corner Soil 60
Carew Falls Rimu leaf litter 42
 Mixed leaf litter 30
Mount French Rimu leaf litter 18
 Mixed leaf litter 63
Kaituna Valley Mixed leaf litter 19
 Total 232
 
 
 
3.2 Selection of fungal isolates for bioactivity 
screening 
From a total of 232 fungal isolates, only 108 of the isolates were selected for bioactivity 
screening. Of the 108 fungal isolates, 85 isolates were selected from the leaf litter 
samples while 23 isolates were selected from the soil sample. The fungal isolates were 
selected randomly based on their cultural characteristics especially colour which often 
represents compounds of interest. Some isolates of common species such as Aspergillus 
sp. and Penicillium sp. were also subjected for bioassay since they are members of very 
productive genera. Figure 3.1 shows those fungal isolates selected for bioactivity 
screening. 
 
All cultures were extracted with ethyl acetate and the extracts subjected to the quick 
screen assay against P388 murine leukemia cell line, Bacillus subtilis, Pseudomonas 
aeruginosa and Candida albicans. The results of the assays are shown in Table 3.2. 
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Figure 3.1 Examples of fungal isolates selected for bioactivity screening. 
 
 
Penicillium sp. (KV2) 
 
 
Penicillium sp. (RF14) 
 
 
Aspergillus sp. (C5) 
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Figure 3.1 Continued 
 
 
Beauveria malawiensis 
 
 
Beauveria sp. (MC3) 
 
 
Verticillium sp. (D1) 
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Figure 3.1 Continued 
 
 
Tolypocladium inflatum 
 
 
Unidentified fungal culture (MF31) 
 
 
Unidentified fungal culture (MF28) 
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Table 3.2 Bioactivity of fungal isolates from soil and leaf litter samples. 
Quick screen (% of cell growth) 
Isolate Extract 
P388 B. subtilis P. aeruginosa C. albicans 
MC3 F8051 36.3 66.2 104.2 104.7 
MC4 F8052 6.8 68.0 100.5 100.1 
MC13 F8053 77.5 100.0 102.7 102.5 
MF2 F8054 79.0 101.4 99.9 100.7 
MF7 F8055 22.8 92.3 102.6 100.7 
MF17 F8056 98.7 101.3 101.9 100.8 
MF18 F8057 41.3 84.0 102.9 103.7 
MF19 F8058 98.5 100.1 103.7 103.1 
RC2 F8059 64.6 86.2 100.6 102.7 
RC3 F8060 66.3 90.0 102.0 101.9 
RC7 F8061 87.1 93.0 101.9 102.3 
RF2 F8062 43.5 92.6 100.9 100.9 
MC5 F8215 79.9 92.8 101.1 104.6 
MC7 F8216 37.9 83.9 101.6 85.2 
MC11 F8217 18.2 87.3 101.6 92.0 
RF3 F8218 66.1 96.6 107.5 105.4 
RF6 F8219 31.3 94.8 99.4 106.4 
MF14 F8220 49.9 97.9 100.9 112.8 
MF17 F8221 2.4 98.1 103.3 84.1 
RC1 F8222 52.4 72.8 101.2 94.9 
RC9 F8223 7.5 93.2 107.4 88.9 
MC10 F8224 102.0 84.1 107.5 97.3 
MC15 F8225 68.3 85.1 100.5 99.6 
MF3 F8226 82.2 94.2 101.8 95.0 
MF9 F8227 59.3 93.7 101.2 78.1 
RC11 F8228 40.6 92.9 105.0 81.4 
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Table 3.2 Continued 
Quick screen (% of cell growth) 
Isolate Extract 
P388 B. subtilis P. aeruginosa C. albicans 
RF9 F8229 73.7 77.9 105.7 101.5 
RF7 F8230 38.7 90.8 74.3 106.2 
MC1 F8231 31.2 83.5 101.2 101.4 
MF1 F8232 92.6 92.4 100.4 85.1 
MF4 F8233 37.3 102.4 100.4 96.8 
MF5 F8234 94.8 99.0 104.4 105.7 
MF11 F8235 90.5 101.3 105.0 105.8 
MF20 F8236 65.9 97.5 99.8 109.9 
MF31 F8237 90.3 91.9 100.3 97.9 
MC6 F8239 14.1 95.8 99.1 106.0 
MC8 F8240 72.3 90.7 105.5 99.4 
MC16 F8241 115.8 96.1 105.4 98.9 
MC20 F8242 108.2 91.2 110.1 111.2 
MF8 F8243 38.8 88.3 100.2 109.8 
MF15 F8244 74.5 96.8 97.3 106.6 
MF24 F8245 69.2 98.4 99.7 96.4 
RF5 F8246 76.5 91.3 104.8 102.9 
RF8 F8247 66.4 89.4 105.1 111.5 
RF10 F8248 52.8 99.2 104.2 101.0 
RF11 F8249 79.9 101.8 99.2 92.5 
RC5 F8250 30.3 94.3 104.2 104.9 
RC10 F8251 57.2 98.8 105.6 105.5 
MC2 F8252 82.7 97.2 105.6 100.2 
MC12 F8253 35.4 90.3 104.9 109.9 
MC14 F8254 69.2 91.2 104.8 106.2 
MC17 F8255 92.9 90.6 100.2 108.0 
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Table 3.2 Continued 
Quick screen (% of cell growth) 
Isolate Extract 
P388 B. subtilis P. aeruginosa C. albicans 
MF6 F8256 3.5 88.4 99.9 103.3 
MF12 F8257 47.5 91.7 99.1 103.9 
MF26 F8258 39.6 101.5 90.3 107.3 
MF25 F8259 79.8 93.6 99.7 111.6 
KV1 F8260 23.5 91.5 99.7 106.1 
KV2 F8261 63.3 77.7 104.9 104.1 
KV7 F8262 6.1 19.0 24.3 30.7 
KV9 F8263 5.5 39.2 104.5 103.2 
KV14 F8264 32.3 72.9 95.6 110.8 
KV15 F8265 58.3 70.8 99.9 86.4 
KV11 F8266 20.6 101.7 105.6 97.7 
KV12 F8267 13.8 82.6 99.9 97.1 
MC18 F8417 56.0 99.9 - 87.4 
RF4 F8418 41.4 99.7 103.8 89.0 
A3 F8419 17.8 100.9 103.9 88.2 
B3 F8420 24.3 98.2 103.1 69.6 
C5 F8421 42.7 102.9 104.2 95.1 
D1 F8422 66.2 103.3 112.4 97.7 
D3 F8423 53.8 104.1 104.7 96.8 
D4 F8424 60.2 102.0 104.2 91.7 
D5 F8425 56.9 103.3 107.1 103.0 
J1 F8426 94.3 101.6 103.6 73.6 
J2 F8427 85.8 102.1 111.1 94.5 
KV4 F8428 73.0 101.0 104.1 107.9 
KV5 F8429 63.6 101.4 105.7 93.1 
KV6 F8430 72.9 92.8 110.8 91.0 
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Table 3.2 Continued 
Quick screen (% of cell growth) 
Isolate Extract 
P388 B. subtilis P. aeruginosa C. albicans 
KV8 F8431 19.6 98.7 106.6 103.5 
KV10 F8432 81.2 97.0 113.0 101.3 
KV13 F8433 8.6 100.2 106.3 102.6 
MC9 F8434 76.7 97.8 104.0 92.6 
MC22 F8435 20.5 103.1 105.2 70.1 
MF10 F8436 63.1 102.6 102.2 95.5 
MF23 F8437 86.3 104.2 103.3 94.2 
RC12 F8438 37.5 103.2 102.4 105.6 
RC13 F8439 1.9 96.4 101.6 100.2 
D6 F8440 36.3 100.3 101.8 98.3 
L F8441 -0.3 102.8 102.0 98.5 
MC21 F8442 74.0 103.5 102.1 86.2 
MF27 F8443 8.0 102.0 103.0 87.0 
RF14 F8444 75.6 102.3 102.9 92.7 
G1 F8445 33.1 104.3 111.3 93.6 
G2 F8446 -0.3 102.8 110.9 95.7 
G3 F8447 50.6 103.9 103.5 85.2 
G4 F8448 51.8 103.0 105.6 88.1 
H1 F8449 73.4 102.1 101.4 76.0 
H2 F8450 44.8 103.9 103.3 92.4 
H4 F8451 35.7 103.0 111.3 84.1 
H5 F8452 45.9 101.3 111.0 90.9 
H6 F8453 62.9 103.3 111.9 94.6 
H7 F8454 76.0 100.8 101.2 75.5 
H8 F8455 60.2 103.0 103.9 89.4 
H9 F8456 68.7 100.3 103.8 75.8 
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Table 3.2 Continued 
Quick screen (% of cell growth) 
Isolate Extract 
P388 B. subtilis P. aeruginosa C. albicans 
KV16 F8457 26.7 103.4 110.9 37.4 
KV17 F8458 19.0 102.7 110.4 95.1 
KV18 F8459 23.3 103.6 103.8 35.3 
KV19 F8460 6.4 103.7 103.7 97.6 
 
 
The results above show the percentage of cell growth and the lower the percentage, the 
more active the extract is. Of the 108 extracts assayed, 47 (43.5%) were active only 
against P388 cells, one (0.9%) against both P388 cells and Bacillus subtilis and one 
(0.9%) against P388 and all three microorganisms. 
 
Extracts that inhibited at least 50% of the growth of P388 cells and gave a good HPLC 
trace were then subjected to IC50 assay to determine the concentration required to inhibit 
the growth of the cells before being selected for further investigations. The results for the 
IC50 assay are shown in Table 3.3. While extracts that inhibited at least 50% of the 
growth of microbial cells and gave a good HPLC trace were selected for further 
investigations. 
 
Table 3.3 P388 IC50 assay. 
Isolate Extract IC50 (ng/mL) 
MF7 F8055 14 410 
MF18 F8057 4 157 
MC6 F8239 13 186 
RC5  F8250 25 287 
MC12  F8253 21 172 
MF6 F8256 3 585 
 
 
 32
Chapter 3: Preliminary Screening 
Table 3.3 Continued 
Isolate Extract IC50 (ng/mL) 
KV1 F8260 < 975 
KV7 F8262 3 002 
KV9 F8263 1 950 
KV14 F8264 41 705 
KV11 F8266 < 975 
A3 F8419 4 776 
KV13 F8433 > 125 000 
RC13 F8439 4 134 
L F8441 3 377 
MF27 F8443 55 675 
G2 F8446 2 604 
H2 F8450 48 212 
H4 F8451 32 736 
H5 F8452 44 092 
KV18 F8459 5 484 
 
 
Following bioassay, the active extracts were subjected to HPLC assay to determine which 
peak(s) is/are responsible for the bioactivity before NMR studies. Not all of the active 
extracts were able to be investigated because of time constraints and quantity of extract 
available. In addition there were a few interesting non-active compounds from both 
active and non-active extracts investigated further by NMR. In summary, 6 extracts were 
selected for further investigation, 5 active extracts and one non-active extract. 9 
compounds were isolated from these 6 extracts. Of these 9 compounds, 5 were active 
against P388 cells only, one was active against both P388 cells and Bacillus subtilis and 3 
were not active.  
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Secondary metabolites from Aspergillus sp. (MF7) 
 
 
4.1  Introduction 
The genus Aspergillus was first recorded by Pietro Antonio Micheli, an Italian priest and 
biologist, in 1727 (Samson, 1994) and Aspergillus species were the first fungal organisms 
cultivated on artificial media and studied for their biochemical properties. They are of 
worldwide occurrence and some demonstrate oligotrophy where they are capable of 
growing in nutrient depleted environments such as damp walls. Aspergillus is a 
hyphomyceteous genus, however, the perfect state of some Aspergilli has been reported 
and placed in ascomyceteous genera such as Eurotium, Neosartorya, Emericella and 
Chaetosartorya. 
 
Aspergillus is characterized by the presence of a conidiogenous structure, the 
aspergillum, consisting of a stipe with a bent or T-shaped base (foot cell) and an inflated 
apex (vesicle) bearing simultaneously produced, conidium-bearing cells (phialides). 
Phialides may be borne directly on the vesicle (uniseriate aspergillum) or with a layer of 
cells (metulae) between the vesicle and phialides (biseriate aspergillum). Raper and 
Fennel (1965) divided the genus into 18 groups and accepted 132 species with 18 
varieties. Since then, many new taxa have been described and the validity of these species 
has been reviewed and compiled by Samson (1979; 1992). 
 34
Chapter 4: Secondary metabolites from Aspergillus sp. (MF7) 
 
 
Conidia
Vesicle 
Phialides 
Metulae 
Stipe 
Figure 4.1 Characteristics of the conidiophores of Aspergillus spp. 
 
Aspergilli are of importance in many respects. Some Aspergillus spp. possess a broad 
range of biological activities and have been used in the search for novel active 
metabolites. For example, Aspergillus fumigatus has been found to produce various types 
of antimicrobial compounds such as fumifungin (Mukhopadhyay et al., 1987), synerazol 
(Ando et al., 1991) and fumagillin (Han et al., 2000). The genus Aspergillus is also a 
versatile producer of enzymes and citric acid and is used in the fermentation industry for 
large scale production of these products. The range of enzymes produced by species of 
Aspergillus is being steadily extended by the use of recombinant DNA technology 
(Harvey and McNeil, 1993). In addition, Aspergillus species have been used over the 
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centuries by humans to make food and beverages (Kendrick, 1992), especially in Asian 
countries such as Japan, again through fermentation processes. 
 
Aspergillus species are also known for their ability to produce toxic metabolites, 
mycotoxins, which can cause serious effects in humans, animals and plants. For example, 
aflatoxin produced by Aspergillus flavus is both toxic and carcinogenic for humans and 
animals. Aspergillus spp. are of increasing importance as human pathogens. With the 
increase in immunocompromised patients, the incidence of Aspergillus is showing a 
consequent increase. Aspergillus fumigatus is the most notable of these pathogens and 
causes range of conditions from allergic bronchopulmonary aspergillosis to pulmonary 
aspergilloma to invasive aspergillosis. Aspergillus is also recorded as a plant pathogen, 
particularly of fruit such as grapes and citrus (Logrieco et. al., 2007). 
 
 
4.2 Aspergillus sp. (MF7) 
Aspergillus sp. (MF7) was isolated from leaf litter samples collected from Mount French 
(West Coast). Based on its ITS sequence, it was identified as Aspergillus versicolor. 
Figure 4.2 shows colonies of MF7 on PDA. The colony is white at first, turning to 
yellow, orange-yellow to yellow green, often intermixed with flesh to pink colours. 
Conidiophores are hyaline or slightly pigmented with smooth walls. Vesicles are 
subglobose to ellipsoidal and phialides borne on metulae. Conidia globose, brownish and 
conspicuously echinulate. These characteristics are consistent with its designation as 
Aspergillus versicolor.  
 
 
 
 
 
 
 
 
 36
Chapter 4: Secondary metabolites from Aspergillus sp. (MF7) 
 
Surface view Reverse view 
  
 
Figure 4.2 14 day old colonies of Aspergillus versicolor (MF7) on PDA.  
 
4.2.1 Compound isolated from Aspergillus versicolor 
(MF7) 
The crude extract from Aspergillus versicolor (MF7) was yellow in colour and cytotoxic 
in the P388 assay (IC50 value of 14 410 ng/mL). From the HPLC trace, one main peak 
could be detected at 17.3 minutes. The UV profile of the peak had a maximum 
absorbance at 205, 245 and 324 nm. Bioactive profiling confirmed that the one main peak 
(17.3 minutes) contained the cytotoxic compound. 
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Figure 4.3 ELSD chromatogram of extract from Aspergillus versicolor (MF7). 
The UV profile of this compound was compared with the UV library which revealed that 
the peak corresponded to that of sterigmatocystin. Both the UV profile and the retention 
time were almost perfectly matched. For further confirmation of the identity of the 
compound, its molecular weight was also determined by mass spectrometry and found to 
be 324 Da (major ions at 325.3 m/z [M+H]+ and 671.5 m/z [2M+Na]+), which is identical 
to that of sterigmatocystin. 
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Figure 4.4 UV profile of the compound (black) eluted at 17.3 minutes matched with 
UV profile of sterigmatocystin (red) in the UV library database. 
 
Figure 4.5 ESI-MS spectrum for the active compound eluted at 17.3 minutes. 
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4.3 Sterigmatocystin 
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Figure 4.6 Structure of sterigmatocystin. 
 
Sterigmatocystin (C18H12O6) is a toxic metabolite structurally closely related to the 
aflatoxins and consists of a xanthone nucleus attached to a bifuran structure. 
Sterigmatocystin has been reported to be produced by various species of Aspergillus 
including Aspergillus versicolor and Aspergillus nidulans (Cole and Schweikert, 2003) 
and also by Bipolaris sorokiniana (Rabie and Steyn, 1976). It crystallizes as pale yellow 
needles and is readily soluble in methanol, ethanol, acetonitrile, benzene and chloroform. 
 
The toxic effects of sterigmatocystin are much the same as those of aflatoxin B1. It is 
thus considered as a potent carcinogen, mutagen and teratogen. Toxic effects of 
sterigmatocystin-fed laboratory animals have included kidney and liver damage and 
diarrhoea. Skin and hepatic tumours are induced in rats by dermal application. Cattle 
exhibiting bloody diarrhoea and loss of milk production. Aside from being toxic itself, it 
also acts as a biogenetic precursor in the biosynthesis of aflatoxins by Aspergillus 
parasiticus and Aspergillus flavus (Rabie and Steyn, 1976). 
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The International Agency for Research on Cancer has classified sterigmatocystin as a 
group 2B substance indicating its potential carcinogenicity. In practice, the risk is 
relatively low because this substance usually appears in moldy or poor quality products 
such as wheat, maize, animal feed, hard cheese, pecan nuts and green coffee beans where 
the chance of daily exposure for most people is very low. 
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Chapter 5 
 
 
Secondary metabolites from Penicillium sp. (KV1 
and KV11) 
 
 
5.1 Introduction 
Penicillium is a genus that is universal in occurrence. The name Penicillium comes from 
the word “brush”, which refers to the appearance of the spore bearing structures which 
resembles a brush or candelabra in Penicillium. Penicillia are versatile and opportunistic. 
Penicillium is a hyphomyceteous genus but the teleomorphs for many Penicillia are now 
known and placed in the ascomyceteous genera Eupenicillium and Talaromyces. 
 
Penicillium colonies usually growing rapidly in shades of green but can also be white, 
grey, blue or yellow, mostly consisting of a dense felt of conidiophores. Conidiophores 
are single (mononematous) or bundled (synnematous), consisting of a single stipe 
terminating in either a whorl of phialides (simple, monoverticillate) or in a penicillus. 
The penicillus containing branches and metulae (penultimate branches which bear the 
whorl of phialides). All cells between metulae and stipe are referred to as branches. The 
branching pattern can either be one-stage branched (biverticillate-symmetrical), two-
stage branched (biverticillate- asymmetrical) or three or more stage branched. The 
conidiophores arise from the substrate (velvety), from aerial hyphae (lanose), from 
prostrate bundled hyphae (funiculose) or from erect loosely or compactly bundled hyphae 
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(fasciculate or synnematous). Conidiophores are hyaline, smooth or rough walled. 
Phialides are usually flask-shaped consisting of a cylindrical basal part and a distinct 
neck or lanceolate. Conidia usually in long dry chains, divergent or in columns, globose, 
ellipsoidal, cylindrical or fusiform, hyaline or greenish, smooth or roughed walled 
(Samson and Hoekstra, 1984). 
 
 
Conidia 
Phialides 
Branches 
Metulae 
Stipe 
Figure 5.1 Structure of the penicillus. 
 
Penicillium spp. are common causes of fungal spoilage in fruits and vegetables. 
Penicillium italicum and Penicillium digitatum are known to infect citrus fruits, while 
Penicillium expansum is known to cause apple fruit decay. Penicillium expansum not 
only causes fruit decay but also produces the carcinogenic mycotoxin, patulin. This toxin 
may rise to unacceptable levels in fruit destined for processing and may also result in off 
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flavours. Penicillium may also cause disease in humans with Penicillium marneffii as a 
prime example causing Penicillinosis. 
 
The importance of Penicillium can be seen in many ways. Like Aspergillus spp., 
Penicillium spp. possess a broad range of biological activities. Kurobane et al., (1981) 
reported the production of fulvic acid by Penicillium brefeldianum which possessed 
antiviral, antifungal, antioxidant and antibiotic activities. Nam et al., (2000) has reported 
the production of 8-O-methylsclererotiorinamine from Penicillium multicolor which 
showed antimicrobial activity. However, the greatest discovery related to Penicillium was 
made by Alexander Fleming in 1929 who discovered penicillin from Penicillium 
notatum. Penicillin is considered as the drug of the age and precursor to many 
developments in biotechnology especially the pharmaceutical industry. Penicillium spp. 
such as Penicillium roquefortii and Penicillium camambertii have also been used in the 
food industry especially in cheese making to produce cheese such as roquefort and 
camembert. 
 
 
5.2 Penicillium sp. (KV1) and (KV11) 
Two species of Penicillium were selected for further investigations designated KV1 and 
KV11. Both species were of different colony and morphology, but identification to 
species level was not attempted. 
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KV1 
  
KV11 
  
 
Figure 5.2 14 day old colonies of KV1 and KV11 on PDA. 
 
 
5.3 Compounds isolated from Penicillium sp. 
(KV1) 
Based on the quick screen assays, it was shown that the KV1 extract was active against 
P388 cells with an IC50 value of < 975 ng/mL. From the HPLC trace two main peaks 
could be detected. The first peak eluted at 8.6 min and the second peak at 15.0 min. 
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Figure 5.3 ELSD chromatogram of extract from Penicillium sp. (KV1). 
 
5.3.1  KV1A: Compound eluted at 8.6 minutes 
The UV profile of the first peak showed maximum absorbance at 212, 267 and 301 nm. 
HPLC bioactivity profiling revealed the first peak was not the one responsible for the 
cytotoxic activity, however, the compound was still pursued because of the lack of 
matching profiles within the UV library database. An aliquot of this compound was 
submitted for mass spectrometry and NMR spectroscopy for further investigation. 
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Figure 5.4 UV profile of KV1A (8.6 min). 
 
 
 
Figure 5.5 ESI-MS spectrum for KV1A (8.6 min). 
 
 47
Chapter 5: Secondary metabolites from Penicillium sp. (KV1 and KV11) 
As indicated in Figure 5.5, the ESI-MS showed major ions at 227.3 m/z [M+H]+, 453.5 
m/z [2M+H]+ and 475.5 m/z [2M+Na]+. This suggested that the molecular weight of the 
compound was 226 Da. 
 
The proton NMR spectrum of KV1A is shown in Figure 5.6. From the spectrum,             
it was assumed that the peak was actually a mixture of two isomeric compounds.                       
A search was then conducted using the AntiMarin database. The data                    
searched on was one singlet methyl signal (1.63 ppm) and one sp3                          
methine signal (4.37 ppm). The molecular weight entered was 225-227 Da. The search                       
gave 3 hits, trihydroxymellein, 3,4,6-trihydroxymellein and 2,4-dihydroxy-6-(1-
hydroxyacetonyl)benzoic acid. Trihydroxymellein and 3,4,6-trihydroxymellein are an 
inseparable part of diastereoisomers known as 3,4,6,8-tetrahydroxy-3-methyl-3,4-
dihydroisocoumarin. The chemical shift of the methyl group of this compound should be 
about 1.5 ppm which is about the same as shown in the proton NMR spectrum (1.63 
ppm). Based on these evidences, KV1A was identified as 3,4,6,8-tetrahydroxy-3-methyl-
3,4-dihydroisocoumarin. There are two possible diastereoisomers of this compound. 
Since there were inseparable, it was impossible to determine which peaks in the proton 
NMR spectrum arose from which isomer. The structures of the isomeric compounds are 
as shown in Figure 5.7, or their enantiomers. This inseparable mixture has previously 
been reported by Ayer et al., (1987). 
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5.3.1.1 3,4,6,8-tetrahydroxy-3-methyl-3,4-dihydroisocoumarin 
HO
OH
O
OH
OH
O     
O
O
HO
OH
OH
OH
 
 
Figure 5.7 Diastereoisomeric structures of 3,4,6,8-tetrahydroxy-3-methyl-3,4-
dihydroisocoumarin. 
 
3, 4, 6, 8- tetrahydroxy- 3 -methyl-3, 4-dihydroisocoumarin (C10H10O6) is non-active 
compound and was previously isolated by Ayer et al. (1987) as a metabolite of 
Ceratocystis minor, a fungus associated with the blue stain disease of Canadian pine 
trees. From literature review, little information could be found on these compounds. It 
has been reported, however, that this compound was used in the synthesis of 
acetophthalidin, a metabolite which inhibits the progression of the mammalian cell cycle 
by Nomoto and Mori, (1997).   
 
 
5.3.2 KV1B: Compound eluted at 15 minutes  
The UV profile of the second peak had a maximum absorbance at 215, 250 and 304 nm. 
Bioactivity profiling established that this peak was the one responsible for the cytotoxic 
activity of the crude extract. 
 
The UV profile of the compound when searched in the UV library revealed that the peak 
corresponded to that of mycophenolic acid. Both the UV profile and the retention time 
fitted almost perfectly. For further confirmation of the identity of the compound, the 
molecular mass of the compound was measured. From the ESI-MS, the molecular weight 
of the compound was 320 Da (major ions at 321.4 m/z [M+H]+ , 343.4 m/z [M+Na]+, 
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641.8 m/z [2M+H]+ and 663.8 m/z [2M+Na]+), which corresponding exactly of 
mycophenolic acid.  
 
 
% 
nm 
Figure 5.8 UV profile of KV1B (black) (15.0 min) matched with the UV profile of 
mycophenolic acid (red) in the UV library database. 
 
 
Figure 5.9 ESI-MS spectrum for KV1B (15 min). 
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5.3.2.1 Mycophenolic acid 
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Figure 5.10 Structure of mycophenolic acid. 
 
Mycophenolic acid (C17H20O6) was first discovered by an Italian physician, Bartolomeo 
Gosio, in 1893 (Bentley, 2000). Mycophenolic acid or mycophenolate is an 
immunosuppressant drug used to prevent rejection in organ transplantation (Bentley, 
2000). It is usually combined with cyclosporine and a steroid medication. It is 
commercially available as a prodrug mycophenolate mofetil. Mycophenolate mofetil is 
metabolized in the liver to the active moiety mycophenolic acid. Recently, the salt, 
mycophenolate sodium, has also been introduced. 
 
Besides being used as an immunosuppressant, mycophenolic acid has also been used to 
treat autoimmune skin disorders such as psoriasis and sarcoidosis. Psoriasis is a disease 
which affects skin and joints. It commonly causes red scaly patches to appear on the skin. 
Sarcoidosis also known as Besnier-Boeck disease is an immune system disorder 
characterized by non-caseating granulomas. Any organs can be affected, but granulomas 
usually appear in the lungs or the lymph nodes. 
 
The used of mycophenolic acid to treat sickness also causes several side effects. Common 
adverse drug reactions are allergic reaction, unusual tiredness, painful urination and 
severe nausea. Mycophenolate sodium is commonly associated with fatigue, headache 
and cough. Intravenous (IV) administration of mycophenolate mofetil is commonly 
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associated with thrombophlebitis and thrombosis. Infrequent adverse effects include 
insomnia, skin rash and dizziness.    
 
 
5.4 Compounds isolated from Penicillium sp. 
(KV11) 
Based on the quick screen assays, it was shown that the KV11 extract was active against 
P388 cells with an IC50 value of < 975 ng/mL. From the HPLC trace three main peaks 
could be detected. The first peak eluted at 15 min, the second peak at 16.7 min and the 
third peak at 17.6 min. 
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Figure 5.11 ELSD chromatogram of extract from Penicillium sp. (KV11). 
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5.4.1 KV11A: Compound eluted at 15 minutes  
The UV profile of the first peak had a maximum absorbance at 212, 235 and 291 nm. 
P388 HPLC assay showed that the first peak was not the one responsible for the 
cytotoxicity. The UV profile of the compound when searched in the UV library revealed 
that the peak corresponded to that of griseofulvin. Both the UV profile and the retention 
time fitted almost perfectly. 
 
 
% 
nm 
Figure 5.12 UV profile of KV11A (black) eluted at 15 min matched with the UV 
profile of griseofulvin (red) in the UV library database. 
 
To further confirm the identity, the molecular weight of KV11A was determined. From 
the mass spectrum, it was concluded that the molecular weight was 352 Da (major ions at 
353.1 m/z [M+H]+ and 705.1 m/z [2M+H]+), exactly the same as griseofulvin. 
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Figure 5.13 ESI-MS spectrum for KV11A eluted at 15 minutes. 
 
5.4.1.1 Griseofulvin 
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Figure 5.14 Structure of griseofulvin. 
 
Griseofulvin (C17H17ClO6) has been used in the treatment of dermatophyte infections for 
the past 40 years. It was first isolated from Penicillium griseofulvum by Oxford et al. in 
1939. The useful biological activity against dermatophytes was not noticed at that time. 
The studies of Blank and Roth later confirmed the role of griseofulvin in dermatological 
therapeutics (Finkelstein et al., 1996). 
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It has been used for the treatment of infections caused by Epidermophyton, Trichophyton 
and Microsporum spp. which cannot be cured by topical antifungal therapy. Griseofulvin 
has also been used for treatment of various other diseases including lichen planus, 
scleroderma, gout, herpes zoster and monilethrix, however, it is not considered to be the 
first line treatment for these diseases (Erkel, 1997).  
 
Studies of the mode of action of griseofulvin revealed that it binds to tubulin, interfering 
with microtubule function, hence inhibiting mitosis. Side effects caused by using 
griseofulvin are hives, confusion, fatigue, itching, swelling and inability to fall or stay 
asleep. 
 
 
5.4.2 KV11B: Compound eluted at 16.7 minutes  
The UV profile of the second peak had a maximum absorbance at 216, 256 and 306 nm. 
P388 HPLC assay showed that this peak was responsible for the cytotoxic activity. The 
UV profile of the compound was searched against the UV library database which 
revealed that the peak corresponded to that of cycloaspeptide. Both the UV profile and 
the retention time were almost perfectly matched. However, there are several types of 
cycloaspeptide. In order to confirm which cycloaspeptide was isolated from this extract, 
an aliquot of the compound was submitted for mass spectrometry and NMR spectroscopy 
for further investigations.  
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Figure 5.15 UV profile of KV11B (black) eluted at 16.7 min matched with the UV 
profile of cycloaspeptide (red) in the UV library database. 
 
As indicated in Figure 5.16, the ESI-MS showed major ions at 642.3 m/z [M+H]+ and 
1283.5 m/z [2M+H]+. This suggested that the molecular weight of the compound was 641 
Da. 
 
Figure 5.16 ESI-MS spectrum of KV11B eluted at 16.7 min. 
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In the 1HNMR spectrum of KV11B (Figure 5.17), five methyl signals of which two were 
doublet methyl groups (0.36 and 0.99 ppm), one triplet methyl group (1.00 ppm) and 2 
N-methyl (2.73 and 2.87 ppm) were recognized. When this data and the molecular weight 
(640-642 Da) was searched against AntiMarin, 2 hits, cytorhodin L and cycloaspeptide A 
were identified. Since the initial identity of the isolated compound was cyclosapetide as 
shown in the UV library, it was concluded that KV11B was cycloaspeptide A. 
 
5.4.2.1 Cycloaspeptide A 
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Figure 5.18 Structure of cycloaspeptide A. 
 
Little has been reported on the activity of cycloaspeptide A (C36H43N5O6), however 
moderate activity against Plasmodium falciparum was shown by Dalsgaard et al., (2005) 
who also indicated that cycloaspeptide A is inactive against P388 cells. This is 
inconsistent with the results obtained here where moderate activity was seen. 
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5.4.3 KV11C: Compound eluted at 17.6 minutes  
The UV profile of the third peak had a maximum absorbance at 230, 237 and 245 nm. 
P388 HPLC assay showed that this peak was also responsible for the cytotoxic activity. 
The UV profile of the compound was searched against the UV library database. No 
match was found. An aliquot of this compound was submitted for mass spectrometry and 
NMR spectrometry for further investigations. 
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nm 
Figure 5.19 UV profile of KV11C (17.6 min). 
 
As indicated in Figure 5.20, the ESI-MS shows major ions at 391.3 m/z [M+H]+, 781.5 
m/z [2M+H]+ and 803.4 m/z [2M+Na]+. This indicated that the molecular weight of the 
compound was 390 Da. 
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Figure 5.20 ESI-MS spectrum for KV11C (17.6 min). 
 
From the 1HNMR spectrum of KV11C (Figure 5.21), three methyl signals of which two 
were doublet methyl groups (0.92 and 1.13 ppm) and one a triplet methyl group (1.00 
ppm) could be identified. The molecular weight was also entered (389-391 Da). The 
result of the search gave 2 hits, mevastatin and mevinic acid. Comparison of the 1D 
proton NMR data with published data (Keck and Kachensky, 1986) of synthetic 
mevastatin combined with the analysis of 2D proton NMR data established that KV11C 
was mevastatin. 
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Assigments 
1H NMR (ppm)(mult) reported 
here (CD3OD) 
1H NMR (ppm)(mult) reported 
in the literature (CDCl3) 
18 0.91 (t) - 
23 0.92 (d) 0.90 (d) 
22 1.13 (d) 1.12 (d) 
19 1.50, 1.70 (m) - 
14 1.75, 1.92 (m) 1.92 (m) 
 2.14 (m) 2.14 (m) 
1, 20 2.39 (m) 2.36 (m) 
16 2.53 (m) - 
 2.72 (m) 2.70 (m) 
15 4.25 (m) 4.35 (m) 
13 4.64 (m) 4.46 (m) 
8 5.33 (m) 5.34 (m) 
5 5.54 (m) 5.56 (m) 
2 5.74 (m) 5.73 (dd) 
3 5.96 (m) 5.98 (d) 
 
Table 5.1 Comparison of the 1H data of mevastatin with published literature (Keck 
and Kachensky, 1986). 
 
5.4.3.1 Mevastatin 
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Figure 5.22 Structure of mevastatin. 
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Mevastatin (C23H34O5), also known as compactin or ML-236 B, is a hypolipidemic agent 
that belongs to the statin class of compounds. It was first isolated in the 1970s from 
Penicillium citrinum. Mevastatin works as a competitive inhibitor of 3-hydroxy-3-
methyl-glutaryl (HMG)-CoA reductase, which is a regulatory enzyme for cholesterol 
biosynthesis (Chakravarti and Sahai, 2004). 
 
Cholesterol is an essential component of cell membranes and a precursor of various 
hormones, bile salts and vitamins. It is synthesized from acetyl-CoA via a series of more 
than 20 enzymatic reactions. This synthetic pathway is mainly regulated by the activity of 
the enzyme HMG-CoA reductase, which catalyzes the reduction of HMG-CoA to 
mevalonate (Endo, 1985). 
 
Inhibition of the conversion of HMG-CoA to mevalonate by mevastatin will result in 
accumulation of HMG-CoA that are metabolized to simpler compounds, thereby making 
it an ideal compound for treatment of atherosclerosis. Aside from being used as an 
inhibitor in cholesterol biosynthesis, mevastatin also acts as a precursor of other statins 
such as pravastatin. 
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Chapter 6 
 
 
Secondary metabolites from Phoma sp. (MF18 and 
KV9) 
 
 
6.1  Introduction 
Phoma is the largest and most widely distributed genus of the Sphaeropsidales, with 
species reported from soil, as saprophytes on various plants and on dead plant material. It 
has a complicated history since it was initially introduced more than 180 years ago. 
During this period, thousands of non-stromatic species of pycnidial fungi which produce 
hyaline conidia without septa were described according to Saccardo’s concept. This 
system placed emphasis on host specificity and presence or absence of a septum. The first 
modern studies on Phoma were carried out by Dennis (1946), introducing in vitro 
characters. This formed the basis for a more sophisticated and natural circumscription of 
the Saccardoan form-genera by Kovics et al., 2005. 
 
Phoma colonies can be characterized by having pigmented separate pycnidia (pycnidial 
conidiomata), usually each with single ostioles, sometimes multiostiolate. Conidiogenous 
cells with a narrow phialidic opening, more or less the same structure as inner-cells of 
pycnidia, producing abundant slimy conidia. Conidia are usually one-celled, ellipsoidal to 
cylindrical, hyaline or coloured. Chlamydospores in some species formed in single chains 
or aggregated in dicytochlamydospores (Samson and Hoekstra, 1984). 
 65
Chapter 6: Secondary metabolites from Phoma sp. (MF18 and KV9) 
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C 
Figure 6.1 Pycnidium of Phoma sp. (A) Side view; (B) top view; (C) Conidia within 
pycnidial cavity. 
  
 
Phoma has been reported to produce some interesting active metabolites with some of 
importance to the pharmaceutical industry. Alvi et al. (1997) a reported the production of 
phomacins, an antitumor agent, from Phoma sp. isolated from a soil sample and Singh et 
al. (1997) also reported the production of an antitumor agent, fusidienol A,  from a 
Phoma sp. isolated from a vegetation sample. 
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6.2 Phoma sp. (MF18) and (KV9) 
Both cultures, MF18 and KV9, were isolated from leaf litter samples. The sample for 
MF18 was collected from Mount French (West Coast), while the sample for KV9 was 
collected from the Kaituna Valley, Banks Peninsula. Red pigmentation was produced by 
KV9 mycelial and also into the agar while no pigmentation was visible in MF18 cultures. 
Neither culture produced any fruiting structures so identification was made by ITS 
sequencing. However, identification to the species level was not possible and different 
gene sequences would be required to give a more definitive identification. 
 
 Top view Bottom view 
MF18 
  
KV9 
  
Figure 6.2 14 day old colonies of MF18 and KV9 on PDA. 
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6.3 Compound isolated from Phoma sp. (MF18) 
Quick screen assays established that the MF18 extract was active against P388 cells (IC50 
4 157 ng/mL). From the HPLC trace one main peak could be detected at 10 min. The UV 
profile of the peak had a maximum absorbance at 249.1 nm. Further tests with P388 
HPLC assay confirmed that the one main peak, MF18A, was responsible for the 
cytotoxic effect. 
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Figure 6.3 ELSD chromatogram of extract from Phoma sp. (MF18). 
 
The UV profile of MF18A was then compared against the UV library database but no 
match was found. An aliquot of MF18A was submitted for mass spectrometry and NMR 
spectroscopy for further investigations. 
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Figure 6.4 UV profile of MF18A. 
 
 
Figure 6.5 ESI-MS spectrum for MF18A. 
 
As indicated in Figure 6.5, the ESI-MS showed major ions at 265.1 m/z [M+H]+ and 
551.3 m/z [2M+Na]+. This suggested that the molecular weight of MF18A was 264 Da. 
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Figure 6.6 shows the proton NMR spectrum of MF18A. A search was made using the 
AntiMarin database with input of two methyl signals of which one was singlet methyl 
group (1.26 ppm) and the other was a doublet methyl group (1.24 ppm). The molecular 
weight entered was 640-642 Da. The search resulted in five hits, 9α-
hydroxyparthenolide, dechloromikrolin, phomenone, phomadecalin D and PF-E99376-1. 
Comparison of the 1HNMR data against published data (Kitahara et al., 1991) confirmed 
that MF18A was phomenone. 
 
Assignment 1H NMR (ppm)(mult) reported 
here (CD3OD) 
1H NMR (ppm)(mult) reported in 
the literature (CDCl3) 
15 1.24 (d) 1.27 (d) 
14 1.26 (s) 1.24 (s) 
2 1.36 (dddd) 1.45 (dddd) 
4 1.72 (dq) 1.82 (dq) 
2’ 2.12 (dddd) 2.17 (dddd) 
1’ 2.35 (ddd) 2.36 (ddd) 
1 2.61 (ddt) 2.54 (ddt) 
6 3.40 (s) 3.38 (s) 
3 3.59 (ddd) 3.64 (ddd) 
12’ 4.18 (d) 4.20 (d) 
12 4.29 (d) 4.33 (d) 
13’ 5.21 (s) 5.33 (s) 
13 5.26 (s) 5.40 (s) 
9 5.72 (d) 5.79 (d) 
 
Table 6.1 Comparison of 1HNMR data of phomenone with published literature 
(Kitahara et al., 1991). 
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6.3.1 Phomenone 
 
O
OH
O
HO
 
 
Figure 6.7 Structure of phomenone. 
 
Phomenone is a known phytotoxic and mycotoxic sesquiterpene which has the 
eremofilane ring structure similar to PR toxin. It was first identified from a pathogenic 
fungus, Phoma exigua var. inoxydabilis (Kitahara et al., 1991).  
 
In the 1970s and 80s, phomenone was shown to act as a growth inhibitor of tomato 
(Capasso et al., 1986). Twenty years later, people started to become aware of the 
cytotoxic activity of phomenone. Isaka et al., (2000) and Seephonkai et al., (2002) 
reported that phomenone exhibits strong cytotoxicity to KB and BC-1 cancer cells. We 
also demonstrated that it was active against P388 cells. However, phomenone also shows 
toxicity against normal cells which led to its limitation for further clinical study and 
biopharmaceutical uses. Currently, work is being undertaken to modify its structure in an 
attempt to reduce toxicity (Weerapreeyakul et al., 2007). 
 
 
6.4 Compound isolated from Phoma sp. (KV9) 
Based on the quick screen assays, it was shown that the KV9 extract was active against 
Bacillus subtilis and P388 cells (IC50 1 950 ng/mL). From the HPLC trace one main peak, 
KV9A, could be detected at 18.7 min. The UV profile of KV9A had a maximum 
absorbance at 241.5, 305.5 and 484.4 nm. Further bioactivity profiling (P388 and 
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antimicrobial) confirmed that the single main peak was responsible for both the cytotoxic 
and antimicrobial effects. 
 
m
A
U
 
Min 
Figure 6.8 ELSD chromatogram of extract from Phoma sp. (KV9). 
 
 
% 
nm 
Figure 6.9 UV profile of KV9A. 
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The UV profile of the compound was compared against the UV library database but no 
match was found. An aliquot of this compound was submitted for mass spectrometry and 
NMR spectroscopy for further investigations. 
 
The 1HNMR spectrum of KV9A is shown in Figure 6.10. A search in AntiMarin 
database with input of 5 methyl signals of which one was a singlet methyl group (1.94 
ppm), three triplet methyl groups (0.89, 0.90 and 1.04 ppm) and one methoxyl group 
(3.83 ppm) gave 17 hits, however, none of the hits had a similar proton NMR spectra to 
KV9A. This suggested that KV9A was possibly a new compound. 
 
An aliquot of the compound was subjected to HSQC and HMBC NMR experiments to 
determine its structure. Poor results allowed only a fragment of the compound to be 
deduced. 
 
Assignment HNMR (δH) HSQC (δC) HMBC (δC) 
1 0.90 11.4 30, 34.9 
7 1.04 19.5 30, 34.9, 140 
6 1.94 12.1 127.6 
 3.54 54.4 94.7 
 3.83 55.1 152.4 
 
Table 6.2 Summary of HNMR, HSQC and HMBC results. 
 
 
6 7 
1 
5 3 2 
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Figure 6.11 Substructure of KV9A based on the 1HNMR, HSQC and HMBC results. 
 
A search was done using the fragment of KV9A and the information from the 1HNMR 
spectrum and it was shown that KV9A was related to laccaridiones A and B which was 
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reported by Berg et al., (2000). Laccaridione A has a maximum UV absorption at 239, 
298 and 481 nm. Laccaridione B has a maximum UV absorption at 239, 299 and 480 nm. 
The UV absorption of both laccaridiones A and B are relatively similar to KV9A (241.5, 
305.5 and 484.4 nm). Laccaridiones A and B are inhibitors of a series of proteases such 
as trypsin, papain, thermolysin, collagenase and zinc-protease from Bacillus subtilis. 
Besides that, laccaridione B has also been reported to show strong antiproliferative effect 
on the murine fibroblast cell line L-929 and the human leukemia cell like K-562 (Berg et 
al., 2000). 
 
O
ROH
O
O
O
 
Laccaridione A R = OCH3
Laccaridione B R = OCH2CH3
Figure 6.12 Structures of laccaridiones A and B. 
 
The mass, however was different to laccaridiones A and B. Based on the mass 
spectrometry result (Figure 6.14), the mass was 370 Da (major ions at 371.1 m/z 
[M+H]+), compared to laccaridiones A (384 Da) and B (398 Da). This suggested that the 
R group in KV9A is a hydroxyl group which had not been previously reported. It was 
also observed that KV9A subsequently was methylated and changed to laccaridione A 
after being dissolved in methanol and stored for a few days. 
 
From the 1HNMR spectrum (Figure 6.10), it is apparent that KV9A is a mixture of 
diastereoisomers, with the hydroxyl group at the hemiacetal position occurring in two 
different orientations. This is evidenced from the appearance of the hemiacetal proton as 
two singlets at ~6.32 ppm and integrating in total for one proton. The methyl triplets and 
doublets at 0.90 and 1.04 ppm respectively are overlapping due to slight chemical shift 
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differences for these methyl signals in the two diastereoisomers. The stereochemistry of 
the methyl group in the side chain is not known.   
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Figure 6.13 Proposed structure of KV9A. 
 
 
Figure 6.14 ESI-MS spectrum for KV9A. 
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Chapter 7 
 
 
Secondary metabolites from a sterile 
dematiaceous fungus (RC7) 
 
 
7.1 Sterile fungus (RC7) 
An unidentified fungus (RC7) was isolated from leaf litter samples collected from Carew 
Falls (West Coast). The colony was white at first turning to dark brown. Colony on PDA 
floccose, developing ‘tufts’ of hyphae, later becoming melanized and resembling 
sclerotial initials. Sporulation was not observed over many months cultivation. 
 
Surface view Reverse view 
  
 
Figure 7.1 4 week old colonies of RC7 on PDA. 
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7.2 Compound isolated from unidentified fungus 
(RC7) 
Based on the quick screen assays, it was shown that RC7 extract did not produce any 
active compounds. From the HPLC trace a single main peak, RC7A, could be detected at 
12.4 minutes.  
 
 
 
Figure 7.2 ELSD chromatogram of extract from unidentified fungus (RC7). 
 
The UV profile of the peak showed a maximum absorbance at 226 nm which when 
compared with the UV library database, showed no match and thus was considered 
worthy of further investigation. An aliquot of RC7A was submitted for mass 
spectrometry and NMR spectroscopy. 
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Figure 7.3 UV profile of RC7A. 
 
 
Figure 7.4 ESI-MS spectrum for RC7A. 
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As indicated in Figure 7.4, the ESI-MS showed major ions at 307.2 m/z [M+H]+, 613.3 
m/z [2M+H]+ and 635.3 m/z [2M+Na]+ suggesting a molecular weight of 306 Da. 
 
Figure 7.5 shows the 1HNMR spectrum of RC7A. A search was performed using the 
AntiMarin database. The information entered for the search was 3 methyl signals of 
which one was a singlet methyl group (2.08 ppm), one doublet methyl group (0.96 ppm) 
and one triplet methyl group (0.91 ppm). The molecular weight entered was 305-307 Da. 
The result was no hit suggesting that RC7A was possibly a new compound. An aliquot of 
RC7A was submitted for HSQC and HMBC spectroscopy to determine its structure. 
Figures 7.6 and 7.7 show the HSQC and HMBC results for RC7A. Table 7.1 
summarizes the HNMR, HSQC and HMBC results of RC7A. 
 
 
Figure 7.6 HSQC spectrum of RC7A. 
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Figure 7.7 HMBC spectrum of RC7A. 
 
Table 7.1 Summary of HNMR, HSQC and HMBC results of RC7A. 
Assignment HNMR HSQC HMBC 
1 0.91 13.5 19.6, 35.7 
2 1.4 19.6 - 
2’ 1.3 19.6 - 
3 1.11 35.7 - 
3’ 1.43 35.7 - 
4 1.78 33.3 - 
5 3.30 75.4 - 
5’ 3.80 75.4 16.2 
6 4.26 103.6 75.4 
7 3.26 74.0 - 
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Table 7.1 Continued 
Assignment HNMR HSQC HMBC 
8 3.53 74.7 71.6, 74.0 
9 4.74 71.6 74.5, 171 
10 3.42 74.5 - 
11 0.96 16.2 33.3, 35.7, 75.4 
12 3.52 61.3 - 
12’ 3.60 61.3 - 
14 2.08 20.0 171 
 
Based on the assignments and connectivities shown above, the compound as shown in 
Figure 7.8 was constructed. The stereochemistry of the monosaccharide unit was 
determined from the coupling constants observed in the 1HNMR spectrum. Preliminary 
values were extracted by inspection of the 1HNMR spectrum and then these values 
together with the observed chemical shifts of the protons, were entered into a spin-
simulation package on the NMR spectrometer. The values were adjusted manually so as 
to generate a calculated spectrum identical to the observed spectrum. The values finally 
obtained are shown in Table 7.2. It is seen that all of the vicinal coupling constants for 
the ring protons are in the range 7.7-9.6 Hz, consistent with dihedral angles between each 
vicinal proton pair of ~180°. This established the stereochemistry of the monosaccharide 
as being that of β-glucopyranose.   
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Figure 7.8 Proposed structure of RC7A. 
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Assignment Coupling constant (Hz) 
J8,9 9.60 
J9,10 9.60 
J6,7 7.70 
J12,12’ 12.00 
J10,12 2.50 
J10,12’ 5.70 
J7,8 9.30 
 
Table 7.2 Values of coupling constants for RC7A. 
 
RC7A (without the acetyl group attached to C9-O) has been reported to be used as a 
substrate to study the transglucosylation process of β-glucosidase from different sources 
(Svasti et al., 2003). Kawabata et al. (2007) has also reported few related compounds to 
RC7A in their study on regioselective acylation on monosaccharides. None of these 
reports gave any spectroscopic data for the related compounds. 
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Conclusions 
 
 
CONCLUSIONS 
 
A total of 232 fungal cultures were isolated from leaf litter and soil samples collected in 
New Zealand using a particle filtration technique. In spite of many decades of research on 
soil and litter organisms, there still remains a large untapped potential in the discovery of 
new isolates with possibility of producing new bioactive compounds. The use of selective 
isolation techniques as studied here enables selection of slower growing and ‘rarer’ 
isolates which would not normally be recovered because of the many rapidly colonizing 
species obtained with many other techniques. 
 
The bioactive screens used in this study were very limited and further screens would be 
highly desirable to determine bioactivities other than cytotoxicity on one cell line and 
activity against few microorganisms. Even given this limitation, some 45% of the 
selected isolates showed some bioactivity. The other 55% remain as a potential source for 
the future discovery of novel compounds with other bioactivity.   
 
CapNMR has proved to be invaluable in characterizing the compounds investigated. It 
enabled very small quantities of compound to be fully chemically characterized. The use 
of these HPLC/NMR together with both UV library and AntiMarin database proved to be 
significant in the discovery of new compounds as well as identifying known compounds.  
 
Nine compounds, including two new compounds (compound KV9A and RC7A), were 
chosen for further investigations. Five compounds were found to be active against P388 
cells (sterigmatocystin, phomenone, mycophenolic acid, cycloaspeptide A and 
mevastatin). One compound, griseofulvin, was active against dermatophytes; another, 
KV9A, was active against both P388 cells and Bacillus subtilis while two more were 
inactive (compound RC7A and 3,4,6,8-tetrahydroxy-3-methyl-3,4-dihydroisocoumarin). 
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Conclusions 
In conclusion, fungi remain as an important source for producing a wide range of 
potentially useful secondary metabolites. The investigation of unique habitats, extreme 
environments and utilizing selective techniques such as particle filtration should yield 
handsome rewards. 
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